PM Holding Appoints Angela Weston as Chief Commercial Officer

Verona, Italy (11 September 2019) – PM Holding, a group of diverse service providers in the life sciences industry, announces the appointment of Angela Weston as Chief Commercial Officer to manage business development operations across the entire group. PM Holding consists of specialized service providers in the drug and device development sector including: CROS NT…

CROS NT Appoints Sébastien Gerin as Chief Operating Officer

Verona, Italy (20 August 2019) – CROS NT announces that Sébastien Gerin has recently joined its global team in the role of Chief Operating Officer. Sébastien stepped into the new position this June as CROS NT continues to expand its global operations in terms of expert biometrics services and full service capacity in select geographic…

PM Holding Companies Join Healthcare Businesswoman’s Association

CROS NT, seQure and Arithmos have become a corporate partner and members of the women’s association Verona, Italy (20 June 2019) – PM Holding, a life sciences holding company comprised of CROS NT, seQure and Arithmos, announced a corporate sponsorship and membership for all three companies with Healthcare Businesswomen’s Association (HBA). HBA is a global…

CROS NT Celebrating 25 Years in Business

01 June 2017 (Chapel Hill, NC, USA) – CROS NT today announced that the company is exhibiting at the DIA 2017 Annual Meeting taking place in Chicago, Illinois June 18-22, 2017. In addition, the company is celebrating 25 years in business by holding a cake-cutting ceremony at its booth on Tuesday, June 20 at 1:30 p.m.…

CROS NT Announces Extended Partnership with Medidata – Deploys RaveX

23 May 2017 (Maidenhead, UK and Chapel Hill, NC, USA) – CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata. Under the partnership, CROS NT will offer its customers with RaveX—the latest generation of Medidata’s industry-leading EDC system, Medidata Rave®—as well as Medidata’s randomization and trial supply management…

CROS NT Expands Global Operations with New Office in India

January 17, 2017 – Verona, Italy and Chapel Hill, NC – CROS NT, a patient-centric and data driven CRO, today announced today the opening of its new office in Bangalore, India. The Bangalore office is the fourth global office established by CROS NT in the last six years, including branches in Italy, Germany, the United Kingdom…

CDISC Launches Data Standards User Guide for Breast Cancer

This month, the Clinical Data Interchange Standards Consortium (CDISC) unveiled data standards user guidelines for breast cancer. CROS NT looks at the implications of data standards and smart trial design in the field of breast cancer. Breast Cancer is the most frequently diagnosed cancer in women worldwide. According to CDISC, breast cancer accounts for 23%…

CROS NT Biostatisticians Co-Author Moderate Asthma Study Results in The Lancet Medical Journal

CROS NT’s Chairman, Paolo Morelli, and biostatistician, Marco Pannacci, are co-authors on a recent paper published in the The Lancet Respiratory Medicine featuring the results of a moderate asthma clinical trial sponsored by the Italian Medicines Agency (AIFA). The full article can be found at http://www.thelancet.com/journal/lanres/issue/current in the Lancet’s most recent issue. Paolo Morelli, given…

CROS NT Ltd Announces Acquisition of MDSL International Ltd.

As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International – a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential. CROS NT Ltd, the UK branch of CROS…

CROS NT Receives CIR – French Research Tax Accreditation

CROS NT is pleased to announce that it has received the CIR tax accreditation from the French government for a three-year period. The French R&D tax accreditation, known as Crédit d’Impôt Recherche (CIR), allows French companies who are conducting research to claim corporate tax relief of up to 30% on costs associated with activities outsourced…

CROS NT SRL Announces Acquisition of Stat-Tech Services, LLC

To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat-Tech Services, LLC – a Contract Research Organization (CRO) with extensive expertise in the medical devices sector. The financial details of the transaction remain confidential. CROS NT, an international CRO specializing in biometrics services, see the acquisition as an…

CROS NT Joins DATATRAK Connect™ Partner Program

CROS NT has expanded its life sciences technology portfolio by joining the DATATRAK Connect™ Program – a program which allows for extended service offerings for the drug development process with the goal of reducing study costs and furthering business development objectives. Under this partnership program, CROS NT can provide DATATRAK’s clinical trial technologies including Electronic…

CROS NT Acquires Symphony EDC System

CROS NT acquired Symphony EDC system from Powertrial. Professor Stephen O’Brien, an academic haemotologist from the Northern Institute of Cancer Research at Newcastle University, helped design the system in order to create a user-friendly technology for Investigators. Symphony is now part of CROS NT’s life science technology portfolio. Symphony is a simple and inexpensive technology…